Demographically adjusted norms for the Trail Making Test in native Spanish speakers: Results from the neuropsychological norms for the US-Mexico border region in Spanish (NP-NUMBRS) project.


Journal

The Clinical neuropsychologist
ISSN: 1744-4144
Titre abrégé: Clin Neuropsychol
Pays: England
ID NLM: 8806548

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 29 9 2020
medline: 16 10 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

Despite the wide use of the Trail Making Test (TMT), there is a lack of normative data for Spanish speakers living in the USA. Here we describe the development of regional norms for the TMT for native Spanish speakers residing in the Southwest Mexico-Border Region of the USA. Participants were 252 healthy native Spanish speakers, 58% women, from ages 19 to 60, and ranging in education from 0 to 20 years, recruited in San Diego, CA and Tucson, AZ. All completed the TMT in Spanish along with a comprehensive neuropsychological test battery as part of their participation in the Neuropsychological Norms for the US-Mexico Border Region in Spanish (NP-NUMBRS) project. Univariable and interactive effects of demographics on test performance were examined. T-scores were calculated using fractional polynomial equations to account for linear and any non-linear effects of age, education, and sex. Older age and lower education were associated with worse scores on both TMT A and B. No sex differences were found. The newly derived T-scores showed no association with demographic variables and displayed the expected 16% rates of impairment using a -1 Population-specific, demographically adjusted regional norms improve the utility and diagnostic accuracy of the TMT for use with native Spanish speakers in the US-Mexico Border region.

Identifiants

pubmed: 32985352
doi: 10.1080/13854046.2020.1800099
pmc: PMC8240160
mid: NIHMS1712890
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

308-323

Subventions

Organisme : NIDA NIH HHS
ID : K24 DA040550
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH064907
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH081482
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG052564
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States

Références

Clin Neuropsychol. 2021 Feb;35(2):356-373
pubmed: 31913746
NeuroRehabilitation. 2015;37(4):639-61
pubmed: 26639932
Clin Neuropsychol. 2021 Feb;35(2):396-418
pubmed: 32077791
Clin Neuropsychol. 2021 Feb;35(2):419-432
pubmed: 31928314
Dev Neuropsychol. 2018 Jan;43(1):1-26
pubmed: 29190120
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
Clin Neuropsychol. 2021 Feb;35(2):433-452
pubmed: 31847711
Assessment. 2017 Mar;24(2):183-196
pubmed: 26318386
Ital J Neurol Sci. 1996 Aug;17(4):305-9
pubmed: 8915764
J Clin Exp Neuropsychol. 2011 Aug;33(7):793-804
pubmed: 21547817
Clin Neuropsychol. 2021 Feb;35(2):269-292
pubmed: 32498654
Clin Neuropsychol. 2021 Feb;35(2):339-355
pubmed: 31900055
Arch Clin Neuropsychol. 2007 May;22(4):433-47
pubmed: 17336493
Clin Neuropsychol. 2021 Feb;35(2):324-338
pubmed: 32043418
Neurologia. 2012 Jul-Aug;27(6):319-29
pubmed: 22405214
Arch Clin Neuropsychol. 2009 Jun;24(4):321-41
pubmed: 19661109
Clin Neuropsychol. 2021 Feb;35(2):374-395
pubmed: 33380275
Clin Neuropsychol. 2021 Feb;35(2):293-307
pubmed: 32233833
Clin Neuropsychol. 2021 Feb;35(2):253-268
pubmed: 32319851
Rev Neurol. 2007 Dec 1-15;45(11):655-60
pubmed: 18050096
Clin Neuropsychol. 2008 Jul;22(4):662-5
pubmed: 17853122
J Int Neuropsychol Soc. 1998 Jul;4(4):363-79
pubmed: 9656610

Auteurs

Paola A Suarez (PA)

Hispanic Neuropsychiatric Center of Excellence-Cultural Neuropsychology Program, University of California, Los Angeles , Los Angeles, CA, USA.

Mirella Díaz-Santos (M)

Hispanic Neuropsychiatric Center of Excellence-Cultural Neuropsychology Program, University of California, Los Angeles , Los Angeles, CA, USA.

Maria J Marquine (MJ)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.

Lily Kamalyan (L)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.
San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.

Monica Rivera Mindt (MR)

Department of Psychology and Latin American Latino Studies Institute, Fordham University, The Bronx, NY, USA.
Department of Neurology, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Anya Umlauf (A)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.

Robert K Heaton (RK)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.

Igor Grant (I)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.

Mariana Cherner (M)

Department of Psychiatry, HIV Neurobehavioral Research Program, University of California, San Diego, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH